OTC Pharmaceuticals - Republic of the Congo

  • Republic of the Congo
  • Revenue in the OTC Pharmaceuticals market amounts to US$25.36 in 2024. The market is expected to grow annually by 6.27% (CAGR 2024-2029).
  • The market's largest segment is the segment Skin Treatment with a market volume of US$6.44 in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240 in 2024).
  • In relation to total population figures, per person revenues of US$4.06 are generated in 2024.
  • In the OTC Pharmaceuticals market, 0.4% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Republic of the Congo is experiencing steady growth due to increasing customer preferences for self-medication, changing lifestyles, and rising awareness about preventive healthcare.

Customer preferences:
Customers in the Republic of the Congo are increasingly opting for over-the-counter (OTC) pharmaceutical products due to their convenience and accessibility. The ease of purchasing OTC medications without a prescription allows consumers to quickly address common health issues such as cold and flu symptoms, pain relief, and digestive problems. Furthermore, the affordability of OTC products compared to prescription medications makes them a preferred choice for individuals with limited healthcare budgets.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in the Republic of the Congo is the growing demand for vitamins, minerals, and supplements (VMS). This trend can be attributed to the increasing health consciousness among consumers who are proactively seeking ways to improve their overall well-being. Additionally, the rise in chronic diseases such as obesity, diabetes, and cardiovascular disorders has led to an increased demand for OTC products that can help manage these conditions. Another trend in the market is the growing popularity of natural and herbal remedies. Consumers are becoming more aware of the potential side effects of synthetic drugs and are therefore seeking alternative options. Natural and herbal products are perceived as being safer and more in line with traditional healing practices. This trend is driving the demand for OTC products that are derived from natural sources and have minimal chemical additives.

Local special circumstances:
The Republic of the Congo has a high prevalence of infectious diseases such as malaria and HIV/AIDS. This has led to an increased demand for OTC pharmaceutical products that can help manage the symptoms of these diseases. Additionally, the country's tropical climate and dense vegetation provide an ideal breeding ground for mosquitoes, further driving the demand for OTC anti-malarial products.

Underlying macroeconomic factors:
The Republic of the Congo is experiencing economic growth, which has resulted in an expansion of the middle class. This has led to an increase in disposable income, allowing more individuals to afford OTC pharmaceutical products. Additionally, the government's focus on improving healthcare infrastructure and increasing access to healthcare services has also contributed to the growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in the Republic of the Congo is witnessing growth due to customer preferences for self-medication, the demand for VMS and natural remedies, local special circumstances such as the prevalence of infectious diseases, and underlying macroeconomic factors such as economic growth and government initiatives.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)